E. Demarsin

发表

Characterization of a recombinant single-chain molecule comprising the variable domains of a monoclonal antibody specific for human fibrin fragment D-dimer.

G. Matthyssens, P. Holvoet, D. Collen, 1991, The Journal of biological chemistry.

Polyethylene Glycol–Derivatized Cysteine-Substitution Variants of Recombinant Staphylokinase for Single-Bolus Treatment of Acute Myocardial Infarction

F. Van de Werf, P. Sinnaeve, M. de Maeyer, 2000, Circulation.

Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – IV. Variability in Fibrinolytic Response of Plasma of Several Mammalian Species

D. Collen, H. Lijnen, E. Demarsin, 1984, Thrombosis and Haemostasis.

Structural and Functional Basis of Plasminogen Activation by Staphylokinase

M. de Maeyer, L. Jespers, D. Collen, 1999, Thrombosis and Haemostasis.

Recombinant staphylokinase variants with altered immunoreactivity. III: Species variability of antibody binding patterns.

I. Lasters, L. Jespers, D. Collen, 1997, Circulation.

Recombinant human microplasmin: production and potential therapeutic properties

N. Nagai, D. Collen, B. van Hoef, 2003, Journal of thrombosis and haemostasis : JTH.

The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons

H. Deckmyn, J. Roodt, S. Lamprecht, 2008, Thrombosis and Haemostasis.

Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinase.

G. Matthyssens, P. Holvoet, D. Collen, 1991, The Journal of biological chemistry.

Absence of Synergism Between Tissue-Type Plasminogen Activator (t-PA), Single-Chain UrokinaseType Plasminogen Activator (scu-PA) and Urokinase on Clot Lysis in a Plasma Milieu In Vitro

D. Collen, H. Lijnen, E. Demarsin, 1986, Thrombosis and Haemostasis.

Isolation and characterisation of natural and recombinant staphylokinase

K. Silence, D. Collen, H. Lijnen, 1992 .

Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.

L. Nelles, D. Collen, H. Lijnen, 1988, European journal of biochemistry.

Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.

D. Collen, H. Lijnen, A. Bollen, 1987, The Journal of biological chemistry.

Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.

D. Collen, J. Stassen, E. Demarsin, 1987, Blood.

Isolation and conditioning of recombinant staphylokinase for use in man

D. Collen, M. Mol, J. Stassen, 1993 .

Characterisation of rt-PA I276G, a recombinant human tissue-type plasminogen activator mutant with altered plasmin cleavage site

L. Nelles, D. Collen, H. Lijnen, 1992 .

Characterization of Domain Deletion and/or Duplication Mutants of a Recombinant Chimera of Tissue-Type Plasminogen Activator and Urokinase-Type Plasminogen Activator (rt-PA/u-PAI)

L. Nelles, D. Collen, H. Lijnen, 1990, Thrombosis and Haemostasis.

Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes.

D. Collen, Y. Laroche, E. Demarsin, 2000, Blood.

Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.

L. Nelles, D. Collen, H. Lijnen, 1988, The Journal of biological chemistry.

Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization.

P. Declerck, K. Silence, D. Collen, 1996, Circulation.

Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants.

Y. Engelborghs, B. Vanloo, P. Holvoet, 1995, Biochemistry.

CHARACTERIZATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR MUTANTS PRODUCED BY SITE-SPECIFIC MUTAGENESIS OF LYS

L. Nelles, D. Collen, W. Holmes, 1987, Thrombosis and Haemostasis.